Use of anti-CD3/CD28 mAb coupled magnetic beads permitting subsequent phenotypic analysis of activated human T cells by indirect immunofluorescence

被引:14
作者
Pène, J
Rahmoun, M
Temmerman, S
Yssel, H
机构
[1] CHU Arnaud Vileneuve, INSERM, U454, F-34295 Montpellier 5, France
[2] Free Univ Brussels, Expt Immunol Lab, Erasme Hosp, Brussels, Belgium
关键词
T lymphocytes; cellular activation; monoclonal antibodies; magnetic beads; immunofluorescence; FACS; cytokine production;
D O I
10.1016/j.jim.2003.08.008
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Functional analysis of T lymphocytes requires in vitro stimulation of these cells under experimental conditions that mimic as closely as possible physiological in vivo stimulation and that involve antigen/T cell receptor (TCR)-mediated activation. Because of the low frequency of antigen-specific T cells in human clinical samples, stimulation with a combination of anti-CD3 and anti-CD28 monoclonal antibodies (mAbs) is a preferred method. Interaction of these mAbs with their ligand results in modulation of the mAb-ligand complex from the cell surface. However, as a result of incomplete modulation, CD3/CD28 m,Ab complexes often remain at the cell surface, thereby precluding subsequent indirect immunofluorescence and flow cytometry analysis using mouse immunoglobulin (Ig)-specific antibodies. This is of importance in situations in which no specific fluorochrome-conjugated mAbs are available, such as in screening procedures of Ig-containing hybridoma culture supernatants. We propose here the use of CD3/CD28 mAbs, linked to magnetic beads allowing standardization of the activation conditions, optimal activation of T cells and complete modulation of antigen-antibody complexes from the cell surface. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 22 条
[1]   MODULATION OF LYMPHOCYTE-T DIFFERENTIATION ANTIGENS - POTENTIAL RELEVANCE FOR MULTIPLE-SCLEROSIS [J].
ANTEL, J ;
OGER, JJF ;
JACKEVICIUS, S ;
KUO, HH ;
ARNASON, BGW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (10) :3330-3334
[2]  
BYUN DG, 1994, J IMMUNOL, V153, P4862
[3]  
DAVIS L, 1986, J IMMUNOL, V137, P3758
[4]  
GEPPERT TD, 1987, J IMMUNOL, V138, P1660
[5]   HUMAN T-CELL ACTIVATION .2. A NEW ACTIVATION PATHWAY USED BY A MAJOR T-CELL POPULATION VIA A DISULFIDE-BONDED DIMER OF A 44-KILODALTON POLYPEPTIDE (9.3 ANTIGEN) [J].
HARA, T ;
FU, SM ;
HANSEN, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (06) :1513-1524
[6]   Phenotypic characterization of human CD4+ regulatory T cells obtained from cutaneous dinitrochlorobenzene-induced delayed type hypersensitivity reactions [J].
Lécart, S ;
Boulay, V ;
Raison-Peyron, N ;
Bousquet, J ;
Meunier, L ;
Yssel, H ;
Pène, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) :318-325
[7]  
Levine BL, 1997, J IMMUNOL, V159, P5921
[8]   Antiviral effect and ex vivo CD4(+) T cell proliferation in HIV-positive patients as a result of CD28 costimulation [J].
Levine, BL ;
Mosca, JD ;
Riley, JL ;
Carroll, RG ;
Vahey, MT ;
Jagodzinski, LL ;
Wagner, KF ;
Mayers, DL ;
Burke, DS ;
Weislow, OS ;
StLouis, DC ;
June, CH .
SCIENCE, 1996, 272 (5270) :1939-1943
[9]   Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats [J].
Pène, J ;
Desroches, A ;
Paradis, L ;
Lebel, B ;
Farce, M ;
Nicodemus, CF ;
Yssel, H ;
Bousquet, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (04) :571-578
[10]  
REINHERZ E, 1982, CELL, V3, P735